Production of wart drug with anti Ebola potential set to restart in New Jersey
Hemispherx will make a candidate Ebola treatment being trialled by the US military at its revamped plant in New Jersey.
Archives for March 5, 2015
CRL’s bottom line continues to be driven by biotech growth, CEO says
For the second straight year Charles River Laboratories has seen more of its revenue derived from biotech companies than Big Pharma, CEO James Foster told investors at two conferences on Tuesday and Wednesday.
Patheon: Irix deal about US and Canadian customer demand for local APIs; all staff to be retained
Irix Pharmaceuticals will cater for North American customers’ desire for local supply according to Patheon, which says it plans to retain the API firm’s 180 staff.
Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion
Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told Outsourcing-pharma.com the preclinical CRO may add scale to US operations.
AbbVie buys Pharmacyclics, bags Imbruvica blood cancer blockbuster
AbbVie is set to buy Californian small-molecule maker Pharmacyclics for $21bn (€19bn), cementing its haematology-oncology business.